A comprehensive view of Merck KGaA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Merck KGaA plans to double R&D productivity, introduce one new product or major indication every 1.5 years on average; over 50% of new launches to result from external co-development partnerships and strategic in-licensing of assets

AstraZeneca and MSD's Lynparza combined with abiraterone and prednisone or prednisolone has been recommended in the EU for approval as a treatment for metastatic castration-resistant prostate cancer

Merck KGaA reports Q3 net profit up 21.2% to €926.0M as sales rise 16.8% to €5.8B; life science business records double-digit growth, new products and established healthcare medicines portfolio have strong performance

AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Sanofi, Samsung Biologics partner to reduce emissions in the pharmaceutical supply chain; group operating through the UN’s Sustainable Markets Initiative Health systems task force

Gerresheimer, Merck develop digital twin for primary packaging to further ensure traceability along the pharmaceutical supply chain; the proof of concept uses blockchain, authentication technologies to anchor physical objects securely in the digital world

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count